Drug Education Guide

Atezolizumab (Nurse)

Immunotherapy Monoclonal antibody PD-L1 inhibitor

Atezolizumab (Nurse)

Immunotherapy Monoclonal antibody PD-L1 inhibitor
Light Sensitive Fall Risk
Medication Basics

Drug Name

Atezolizumab. This education entry is the nurse version.

Purpose / Indication

Atezolizumab is used in treatment regimens for selected cancers including lung cancer, liver cancer, melanoma, and other eligible tumors. Confirm disease-specific indication, line of therapy, combination regimen, and institutional protocol before administration.

Dosage & Administration

Dose Schedule

Dose, schedule, cycle length, premedications, and dose modifications are regimen-specific. Verify provider order, protocol, BSA/weight parameters, labs, and hold criteria.

Route

IV (Intravenous)

Timing Considerations

Assess baseline status, review labs, confirm consent as applicable, administer premedications per protocol, and monitor during and after infusion per institutional standards.

Food Relation

Either

Time of Day

Flexible

Special Instructions

Complete medication reconciliation, allergy review, infection screening, pregnancy considerations as applicable, and patient education before treatment.

Injection Techniques

Administer only by trained staff using institutional hazardous drug, biologic, infusion, and extravasation procedures as applicable.

Mechanism of Action

Mechanism

Atezolizumab acts on PD-L1 checkpoint pathway. Teach mechanism at a level appropriate to the learner and connect mechanism to expected toxicities and monitoring.

13 More Sections — Members Only

Free membership unlocks the complete guide.

  • Side Effects
  • Drug Interactions
  • Contraindications
  • Monitoring
  • Adherence
  • + 8 more…